Novoprotein Scientific Inc. (SHA:688137)

China flag China · Delayed Price · Currency is CNY
48.28
-0.82 (-1.67%)
Apr 29, 2026, 4:00 PM EDT
50.03%
Market Cap 3.37B
Revenue (ttm) 146.44M
Net Income (ttm) -77.78M
Shares Out 69.77M
EPS (ttm) -1.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 624,329
Average Volume 1,058,164
Open 48.42
Previous Close 49.10
Day's Range 48.00 - 49.50
52-Week Range 31.99 - 54.56
Beta 1.54
RSI 58.83
Earnings Date Apr 29, 2026

About Novoprotein Scientific

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania. It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, enzymes and reagents, biosimilar reference antibodies, gene and cell therapy, molecular research and diagnosis, and virus-related products, including antigens, antibodies and test kits. The company also provides protein expression and puri... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 556
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688137
Full Company Profile

Financial Performance

In 2025, Novoprotein Scientific's revenue was 146.44 million, an increase of 14.80% compared to the previous year's 127.56 million. Losses were -77.78 million, 42.9% more than in 2024.

Financial Statements

News

There is no news available yet.